Parker Scott L, McGirt Matthew J, Murphy Jeffrey A, Megerian J Thomas, Stout Michael, Engelhart Luella
Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, Tennessee;
J Neurosurg. 2015 Feb;122(2):443-8. doi: 10.3171/2014.10.JNS13395. Epub 2014 Nov 21.
The real-world effectiveness of antibiotic-impregnated shunt catheters to reduce the incidence of shunt infections is still debated. The literature to date consists mostly of small, single-institution studies. The aim of this study was to assess the incidence of infection for antibiotic-impregnated catheters (AICs) versus standard shunt catheters in a large nationwide administrative database.
The authors retrospectively reviewed hospital discharge and billing records from the Premier Perspective Database from April 2003 to July 2009 to identify all adult and pediatric patients undergoing de novo ventricular shunt placement. The primary end point was the incidence of shunt infection within 1 year of implantation. Multivariate logistical regression was performed to determine factors associated with increased incidence of infection.
A total of 10,819 adult (AIC, 963; standard catheter, 9856) and 1770 pediatric (AIC, 229; standard catheter, 1541) patients underwent ventricular shunt placement in 287 US hospitals. Overall, the incidence of infection was 3.5% in adults (n=380) and 6.6% in pediatric patients (n=116). AICs were associated with significant reduction in infection for both adult (2.2% vs 3.6%, p=0.02) and pediatric (2.6% vs 7.1%, p<0.01) patients. AIC use was associated with reduced infection regardless of hospital size, annual shunt volume, hospital location, or patient risk factors and remained associated with a reduced infection in multivariate analysis for both adult (p=0.02) and pediatric (p=0.02) patients.
The use of antibiotic-impregnated shunt catheters was associated with a reduction in shunt infections for both adult and pediatric patients. This provides further support that AICs may represent a reliable means of reducing shunt infections for both adult and pediatric patients.
抗生素浸渍分流导管降低分流感染发生率的实际效果仍存在争议。迄今为止的文献大多是小型的单机构研究。本研究的目的是在一个大型的全国性行政数据库中评估抗生素浸渍导管(AIC)与标准分流导管的感染发生率。
作者回顾性分析了2003年4月至2009年7月Premier Perspective数据库中的医院出院和计费记录,以确定所有接受初次脑室分流置管的成人和儿童患者。主要终点是植入后1年内的分流感染发生率。进行多因素逻辑回归分析以确定与感染发生率增加相关的因素。
美国287家医院共有10819例成人(AIC组963例,标准导管组9856例)和1770例儿童(AIC组229例,标准导管组1541例)患者接受了脑室分流置管。总体而言,成人感染发生率为3.5%(n = 380),儿童患者为6.6%(n = 116)。AIC与成人(2.2%对3.6%,p = 0.02)和儿童(2.6%对7.1%,p < 0.01)患者的感染显著减少相关。无论医院规模、年度分流数量、医院位置或患者风险因素如何,使用AIC均与感染减少相关,并且在成人(p = 0.02)和儿童(p = 0.02)患者的多因素分析中仍与感染减少相关。
抗生素浸渍分流导管的使用与成人和儿童患者分流感染的减少相关。这进一步支持了AIC可能是降低成人和儿童患者分流感染的可靠方法。